elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33403967-AE10A5A6-932D-4360-88A9-D6AD071C02AC
Q33403967-AE10A5A6-932D-4360-88A9-D6AD071C02AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33403967-AE10A5A6-932D-4360-88A9-D6AD071C02AC
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma.
P2860
Q33403967-AE10A5A6-932D-4360-88A9-D6AD071C02AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33403967-AE10A5A6-932D-4360-88A9-D6AD071C02AC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fcf582a3f4af434f3b58d14528136273965ea0a8
P2860
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.